|
Mitochondrial proteins | PTMs | Upstream regulators | Impacts on mitochondrial quality control | Mechanism | Cardiovascular diseases | Roles in cardiovascular diseases | References |
|
Drp1 | SUMOylation | SUMO1 | Positive | Induce autophagy | I/R injury | Weaken myocardial I/R intervention | [43] |
Drp1 | SUMOylation | SENP5 | Positive | Inhibit the activation of apoptosis factor | Heart failure | Relieve heart failure | [47] |
CypD | Ubiquitination | Parkin | Positive | Inhibit the opening of mPTP | I/R injury | Alleviate heart I/R injury | [56] |
OMA1 | Ubiquitination | GSK3 | Positive | Increase OPA1 expression | Heart failure | Relieve heart failure | [66] |
AKAP121 | Ubiquitination | ACSL1 | Negative | Increase mitochondrial division | Cardiomyopathy | Promote the formation of lipotoxic cardiomyopathy | [64] |
Cytochrome C oxidase | Phosphorylation | PKA | Negative | Increase ROS production | I/R injury | Increase myocardial I/R injury | [74, 75] |
STAT3 | Phosphorylation | Unclear | Positive | Improve the respiration of CI, inhibit the opening of MPTP | Relieve myocardial I/R injury | [77–79] |
VDAL | Phosphorylation | HK2 | Negative | Promote apoptosis | Aggravate heart I/R injury | [80] |
Akt | Phosphorylation | PI3K | Positive | Inhibit the opening of mPTP | Myocardial infarction | Alleviate myocardial infarction | [72, 73] |
PINK1 | Phosphorylation | AMPKα2 | Positive | Induce autophagy | Heart failure | Relieve heart failure | [65] |
Drp1 | Phosphorylation | PKA | Negative | Increase mitochondrial division | Aggravate heart failure | [85] |
GSK3β | Acetylation | SIRT3 | Positive | Reduce cardiac fibrosis | Heart failure | Relieve heart failure | [93] |
CypD | Acetylation | SIRT3 | Negative | Induce the opening of mPTP | Heart failure | Aggravate heart failure | [95] |
PGC-1α | Acetylation | SIRT3 | Negative | Destroy mitochondrial membrane potential | Aggravate heart failure | [96] |
FOXO3a | Acetylation | SIRT3 | Negative | Oxidative damage to mitochondria | I/R injury | Aggravate myocardial I/R injury | [102] |
P53 | Acetylation | SIRT1 | Negative | Promote ROS production | | Accelerate myocardial I/R injury | [103] |
Akt/PDK1 | Acetylation | SIRT1 | Positive | Prevent Akt/PDK1 from combining with PIP3 | Myocardial hypertrophy | Reduce myocardial hypertrophy | [105] |
SDH | Succinylation | SIRT5 | Positive | Decrease ROS production | Atrial fibrillation | Relieve myocardial I/R injury | [118] |
Unknown | Succinylation | Unknown | Negative | Increase ROS production | Accelerate myocardial I/R injury | [120] |
ECHA | Succinylation | SIRT5 | Unknown | Accelerate oxidation of fatty acids | Myocardial hypertrophy | Weaken myocardial hypertrophy | [115] |
|